George A Condouris

Title: Innovations and Contributions of George A. Condouris

Introduction

George A. Condouris is a notable inventor located in Glen Ridge, NJ, USA. He holds two patents that reflect his significant contributions to the field of nerve stimulation and pharmacology. His work has the potential to impact medical treatments and the understanding of nerve impulse conduction.

Latest Patents

Condouris's latest patents focus on the development of 1,4-Disubstituted-1,2-dihydro-1,3,5-triazin-2-ones. These innovations provide a method for blocking high-frequency nerve stimulation. The patented compounds selectively act to substantially block high-frequency nerve impulses without significantly affecting the conduction of a single impulse. Notably, the effect of these compounds is reversible upon withdrawal of the drug, offering a promising avenue for temporary nerve impulse modulation.

Career Highlights

Throughout his career, Condouris has made strides in the medical and pharmaceutical industries. He works at William H. Rorer, Inc., where he continues to expand his expertise and contribute to innovative projects. His dedication to research has led to the successful patenting of methods that address complex challenges in nerve stimulation.

Collaborations

George Condouris collaborates with a team of talented professionals, including coworkers John Yelnosky and Richard L. Riley. Together, they create a dynamic work environment that fosters innovation and enhances the development of new medical solutions.

Conclusion

In conclusion, George A. Condouris stands out as a valuable inventor within the medical field. His patents on methods for blocking high-frequency nerve stimulation demonstrate his commitment to enhancing medical treatments. The potential applications of his work continue to pave the way for future innovations in pharmacology and nerve impulse management.